# Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

> **NCT03101995** · PHASE2 · RECRUITING · sponsor: **National Institute of Cancerología** · enrollment: 18 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT03101995
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-16
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101995, "Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03101995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*